Black Bird Biotech Inc (BBBT)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 28, 16:00
Black Bird Biotech Enterprise Value: 0.9097M for May 28, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 28, 2024 | 0.9097M |
| May 24, 2024 | 0.9097M |
| May 23, 2024 | 0.9097M |
| May 22, 2024 | 0.9097M |
| May 21, 2024 | 0.999M |
| May 20, 2024 | 0.9097M |
| May 17, 2024 | 0.9097M |
| May 16, 2024 | 0.9097M |
| May 15, 2024 | 0.9097M |
| May 14, 2024 | 0.999M |
| May 13, 2024 | 1.088M |
| May 10, 2024 | 0.9097M |
| May 09, 2024 | 0.9097M |
| May 08, 2024 | 0.9097M |
| May 07, 2024 | 0.9097M |
| May 06, 2024 | 0.7312M |
| May 03, 2024 | 0.9097M |
| May 02, 2024 | 0.9097M |
| May 01, 2024 | 0.999M |
| April 30, 2024 | 0.9097M |
| April 29, 2024 | 0.9097M |
| April 26, 2024 | 0.9097M |
| April 25, 2024 | 0.9097M |
| April 24, 2024 | 1.088M |
| April 23, 2024 | 1.088M |
| Date | Value |
|---|---|
| April 22, 2024 | 1.088M |
| April 19, 2024 | 1.088M |
| April 18, 2024 | 0.999M |
| April 17, 2024 | 0.999M |
| April 16, 2024 | 0.999M |
| April 15, 2024 | 0.9097M |
| April 12, 2024 | 0.9097M |
| April 11, 2024 | 0.9097M |
| April 10, 2024 | 0.9097M |
| April 09, 2024 | 0.9097M |
| April 08, 2024 | 0.9097M |
| April 05, 2024 | 0.9097M |
| April 04, 2024 | 0.9097M |
| April 03, 2024 | 0.9097M |
| April 02, 2024 | 0.9097M |
| April 01, 2024 | 0.9097M |
| March 28, 2024 | 0.9097M |
| March 27, 2024 | 0.9097M |
| March 26, 2024 | 0.9097M |
| March 25, 2024 | 0.9097M |
| March 22, 2024 | 0.7312M |
| March 21, 2024 | 0.9097M |
| March 20, 2024 | 1.088M |
| March 19, 2024 | 1.088M |
| March 18, 2024 | 1.088M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.7312M
Minimum
Jan 03 2024
30.05M
Maximum
Sep 02 2020
4.521M
Average
2.802M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 6.003M |
| Palatin Technologies Inc | 20.81M |
| iBio Inc | 29.00M |
| Theriva Biologics Inc | -10.62M |
| Oragenics Inc | 9.147M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.1312M |
| Revenue (Quarterly) | 0.0039M |
| Total Expenses (Quarterly) | 0.0148M |
| EPS Diluted (Quarterly) | -0.0001 |
| Gross Profit Margin (Quarterly) | 36.02% |
| Profit Margin (Quarterly) | -3.33K% |
| Earnings Yield | -1.79K% |
| Normalized Earnings Yield | -1792.00 |